Dr Andrew Katelaris graduated from Sydney University with a Batchelor of Medicine in 1982 and was awarded a Doctorate in Medicine in Immunopathology in 1992. He has over twenty years of experience in clinical medicine, forensic pathology and medical research.

Dr Katelaris was the first medically trained practitioner in Australia to publicise the multiple therapeutic benefits of cannabis medicine. Beginning with treating chronic pain and iatrogenic opioid addiction in the 1990’s, he went on to pioneer the use of CBD dominant cannabis in intractable childhood epilepsy. This led to conflict with the Medical Board and deregistration in 2005. Dr Katelaris continues the work as an independent health practitioner.

Dr Katelaris has a long involvement with the industrial uses of cannabis hemp. He obtained the first industrial hemp cultivation licence in 1997 and that early agricultural work culminated in the Industrial Hemp Act in 2008. Dr Katelaris wrote the FSANZ application that was instrumental in having hemp seed legalised as a human food. His current research includes developing advanced dietary interventions to treat chronic diseases and the development of non-toxic hemp plastics.